1. Home
  2. NSPR vs TISI Comparison

NSPR vs TISI Comparison

Compare NSPR & TISI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NSPR
  • TISI
  • Stock Information
  • Founded
  • NSPR 2005
  • TISI 1973
  • Country
  • NSPR United States
  • TISI United States
  • Employees
  • NSPR N/A
  • TISI N/A
  • Industry
  • NSPR Medical/Dental Instruments
  • TISI Other Consumer Services
  • Sector
  • NSPR Health Care
  • TISI Consumer Discretionary
  • Exchange
  • NSPR Nasdaq
  • TISI Nasdaq
  • Market Cap
  • NSPR 74.8M
  • TISI 78.6M
  • IPO Year
  • NSPR N/A
  • TISI N/A
  • Fundamental
  • Price
  • NSPR $2.38
  • TISI $18.71
  • Analyst Decision
  • NSPR Strong Buy
  • TISI
  • Analyst Count
  • NSPR 2
  • TISI 0
  • Target Price
  • NSPR $4.50
  • TISI N/A
  • AVG Volume (30 Days)
  • NSPR 112.3K
  • TISI 6.8K
  • Earning Date
  • NSPR 08-05-2025
  • TISI 08-12-2025
  • Dividend Yield
  • NSPR N/A
  • TISI N/A
  • EPS Growth
  • NSPR N/A
  • TISI N/A
  • EPS
  • NSPR N/A
  • TISI N/A
  • Revenue
  • NSPR $7,066,000.00
  • TISI $870,735,000.00
  • Revenue This Year
  • NSPR $4.85
  • TISI N/A
  • Revenue Next Year
  • NSPR $113.47
  • TISI N/A
  • P/E Ratio
  • NSPR N/A
  • TISI N/A
  • Revenue Growth
  • NSPR 7.60
  • TISI 2.55
  • 52 Week Low
  • NSPR $1.99
  • TISI $10.14
  • 52 Week High
  • NSPR $3.80
  • TISI $26.77
  • Technical
  • Relative Strength Index (RSI)
  • NSPR 44.93
  • TISI 54.83
  • Support Level
  • NSPR $2.35
  • TISI $18.00
  • Resistance Level
  • NSPR $2.52
  • TISI $19.80
  • Average True Range (ATR)
  • NSPR 0.14
  • TISI 1.06
  • MACD
  • NSPR -0.02
  • TISI 0.20
  • Stochastic Oscillator
  • NSPR 7.50
  • TISI 71.38

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

About TISI Team Inc.

Team Inc provides specialty industrial services, including inspection, engineering assessment, and mechanical repair and remediation required in maintaining high-temperature and high-pressure piping systems and vessels utilized in refining, petrochemicals, and others. The company operates in two segments, Inspection and Heat Treating and Mechanical Services. The Inspection and Heat Treating segment, which generates maximum revenue, provides conventional and non-destructive testing services for the process, pipeline, and power sectors, pipeline integrity management services, and field heat treating services, as well as associated engineering and condition assessment services. Geographically, the company derives its key revenue from the United States, followed by other countries, and Canada.

Share on Social Networks: